Boston Children's tops list of best pediatric hospitals in the U.S.

U.S. News & World Report recently released its list of the top children’s hospitals for 2016-2017. Based on clinical data and pediatric specialists, the rankings examined 106 hospitals in 10 major specialties.

Boston Children’s Hospital earned the top spot on the list—and it wasn’t even close. The 395-bed facility was ranked No. 1 in eight of the 10 categories.

Based on data from 183 pediatric centers and responses from 11,000 surveyed pediatric specialists and subspecialists, the report listed 11 hospitals on its Honor Roll, meaning a facility performed at the highest level in three or more specialties:

  1. Boston Children's Hospital
  2. Children's Hospital of Philadelphia
  3. Cincinnati Children's Hospital Medical Center
  4. Texas Children's Hospital, Houston
  5. Seattle Children's Hospital
  6. Ann and Robert H. Lurie Children's Hospital of Chicago
  7. Children's Hospital Los Angeles
  8. Children's Hospital of Pittsburgh of UPMC
  9. Children's Hospital Colorado, Aurora
  10. Lucile Packard Children's Hospital at Stanford, Palo Alto, CA
  1. Nationwide Children's Hospital, Columbus, Ohio

"Families with sick children face so many uphill battles," said Avery Comarow, U.S. News health rankings editor. "By recognizing hospitals that offer the best pediatric care, we hope we can offer families important help when they are going through an exceptionally overwhelming time."

The full list of children’s hospitals can be seen at U.S. News & World Report.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.